Liu and colleagues [80] showed that cisplatin treatment for 24 h remarkably increased the percentage of CD133+ subpopulation cells in two non-small cell lung cancer (NSCLC) cell lines (H460 and H661). This evidence concerns the gene PROM1 and non-small cell lung carcinoma.